Join the club for FREE to access the whole archive and other member benefits.

Spiegel Lab

Research group at Yale university developing synthetic complex molecular targets

The Spiegel Lab focuses on developing new synthetic approaches that will facilitate our understanding and treatment of human disease. Ongoing project areas of interest to the group include:

1. The development of synthetic molecules capable of refocusing the human immune system towards diseased or infected tissues.

2. Total syntheses of complex natural products found in humans. Synthetic access to these materials will allow us to elucidate disease pathways, with an eye toward therapeutics development.

Visit website:

See also: Academia Yale University - Private Ivy League research university in New Haven, Connecticut

Spiegel Lab News

SRF to develop glucosepane-cleaving antibodies with Spiegel Lab (LEAF) - 17-Sep-2017

Anti-glucosepane antibodies may offer new therapies for age-related diseases